Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study-Reference-Cited by-同舟云学术

Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study

Published:2021-09 Issue:7 Volume:50 Page:102119
ISSN:2468-7847
Container-title:Journal of Gynecology Obstetrics and Human Reproduction
language:en
Short-container-title:Journal of Gynecology Obstetrics and Human Reproduction

Author:

Maisonneuve Emeline^ORCID,Dugas Anaïs^ORCID,Friszer Stéphanie,Toly-Ndour Cécile^ORCID,Cariot Laura^ORCID,Dhombres Ferdinand,Cortey Anne,Mailloux Agnès,Carbonne Bruno,Jouannic Jean-Marie^ORCID

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference21 articles.

1. Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn - review on current management and outcome;Zwiers;Expert Rev Hematol,2017

2. Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures;Zwiers;Ultrasound Obstet Gynecol,2017

3. Early intrauterine transfusion in severe red blood cell alloimmunization;Yinon;Ultrasound Obstet Gynecol,2010

4. Revisiting the use of intravenous immune globulin (IVIG) for Kell alloimmunization;Scott;Am J Obstet Gynecol,2018

5. Postponing early intrauterine transfusion with intravenous immunoglobulin treatment; the PETIT study on severe hemolytic disease of the fetus and newborn;Zwiers;Am J Obstet Gynecol,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibiting IgG in Hemolytic Disease of the Fetus;New England Journal of Medicine;2024-08-08

2. Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn;New England Journal of Medicine;2024-08-08

3. Hemolytic disease of the fetus and newborn—a perspective of immunohematology;Hematology, Transfusion and Cell Therapy;2024-08

4. Der neonatale Fc-Rezeptor: Biologische Grundlagen und Potenzial der therapeutischen Blockade in der Behandlung immunhämatologischer Erkrankungen;Transfusionsmedizin;2024-05

5. Clinical response to therapeutic plasmapheresis and intravenous immunoglobulin in pregnancies complicated by alloimmunization despite persistently high titers: Report of two cases;Clinical Case Reports;2023-11